1-183261260-C-T
Variant summary
Our verdict is Pathogenic. The variant received 11 ACMG points: 11P and 0B. PM1PM2PP2PP3_StrongPP5_Moderate
The NM_015039.4(NMNAT2):c.695G>A(p.Arg232Gln) variant causes a missense change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.0000123 in 1,461,708 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Likely pathogenic (★).
Frequency
Consequence
NM_015039.4 missense
Scores
Clinical Significance
Conservation
Publications
Genome browser will be placed here
ACMG classification
Our verdict: Pathogenic. The variant received 11 ACMG points.
Transcripts
RefSeq
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
NMNAT2 | ENST00000287713.7 | c.695G>A | p.Arg232Gln | missense_variant | Exon 9 of 11 | 1 | NM_015039.4 | ENSP00000287713.6 | ||
NMNAT2 | ENST00000294868.8 | c.680G>A | p.Arg227Gln | missense_variant | Exon 9 of 11 | 1 | ENSP00000294868.4 | |||
NMNAT2 | ENST00000464047.1 | n.177G>A | non_coding_transcript_exon_variant | Exon 2 of 4 | 2 |
Frequencies
GnomAD3 genomes Cov.: 32
GnomAD2 exomes AF: 0.0000119 AC: 3AN: 251452 AF XY: 0.00000736 show subpopulations
GnomAD4 exome AF: 0.0000123 AC: 18AN: 1461708Hom.: 0 Cov.: 31 AF XY: 0.00000825 AC XY: 6AN XY: 727176 show subpopulations
GnomAD4 genome Cov.: 32
ClinVar
Submissions by phenotype
not specified Pathogenic:1
The c.695G>A (p.R232Q) alteration is located in exon 9 of the NMNAT2 gene. This alteration results from a G to A substitution at nucleotide position 695, causing the arginine (R) at amino acid position 232 to be replaced by a glutamine (Q). Based on data from gnomAD, the A allele has an overall frequency of <0.01% (3/251452) total alleles studied. The highest observed frequency was <0.01% (3/113734) of European (non-Finnish) alleles. This amino acid position is highly conserved in available vertebrate species. The p.R232 amino acid is located in the NAD binding pocket of the NMNAT2 enzyme and is found to be crucial for the function of the protein due to its direct interaction with NAD. Homology modeling of this amino acid alteration conducted internally at Ambry Genetics using the published crystal structure of the homologous NMNAT3 protein (Zhang, 2003) indicated that this alteration would disrupt the interaction of NMNAT2 with NAD and thereby its function in the biosynthesis of NAD. This alteration is predicted to be deleterious by in silico analysis. Based on the available evidence, this alteration is classified as likely pathogenic. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at